BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26443969)

  • 1. Successful treatment with intravenous high-dose immunoglobulin for cardiomyopathy in dermatomyositis complicated with rapid progressive interstitial pneumonia.
    Yoshimatsu Y; Kotani T; Fujiki Y; Oda K; Kataoka T; Yamairi K; Hata K; Otani K; Kamimori T; Fujiwara H
    Int J Rheum Dis; 2019 Feb; 22(2):321-324. PubMed ID: 26443969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review.
    Stewart JA; Price T; Moser S; Mullikin D; Bryan A
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):16. PubMed ID: 35193600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome in adult dermatomyositis: a case-based review.
    Kishida D; Sakaguchi N; Ueno KI; Ushiyama S; Ichikawa T; Yoshinaga T; Shimojima Y; Sekijima Y
    Rheumatol Int; 2020 Jul; 40(7):1151-1162. PubMed ID: 32356114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
    Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K
    Lung; 2009; 187(3):201-6. PubMed ID: 19387736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.
    Hisanaga J; Kotani T; Fujiki Y; Yoshida S; Takeuchi T; Makino S
    Int J Rheum Dis; 2017 Dec; 20(12):2182-2185. PubMed ID: 28752606
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.
    Nandy A; Gaïni S; Sore P
    Scand J Rheumatol; 2018 Jul; 47(4):334-335. PubMed ID: 29043891
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
    Conway R; O'Donnell R; Fahy R; Doran MF; Cunnane G; O'Shea FD
    QJM; 2014 Jul; 107(7):593-4. PubMed ID: 24336848
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
    Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S
    Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis Treated with Combination of Immunosuppressive Therapy, Direct Hemoperfusion with a Polymyxin B Immobilized Fiber Column and Intravenous Immunoglobulin.
    Takai M; Katsurada N; Nakashita T; Misawa M; Mochizuki T; Kaneko N; Motojima S; Aoshima M
    Intern Med; 2015; 54(17):2225-9. PubMed ID: 26328651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin.
    Mizoguchi F; Takada K; Ishikawa K; Mizusawa H; Kohsaka H; Miyasaka N
    Mod Rheumatol; 2015 Jul; 25(4):646-8. PubMed ID: 24252047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A.
    Shimojima Y; Ishii W; Kato T; Hoshi K; Matsuda M; Hashimoto T; Tanaka Y; Ikeda S
    Intern Med; 2003 Dec; 42(12):1253-8. PubMed ID: 14714970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with regimen of intravenous gamma globulin and cyclophosphamide for dermatomyositis accompanied by interstitial pneumonia, opportunistic infection and steroid psychosis.
    Murota H; Muroi E; Yamaoka T; Hamasaki Y; Katayama I
    Allergol Int; 2006 Jun; 55(2):199-202. PubMed ID: 17075258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
    J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody.
    Zou J; Li T; Huang X; Chen S; Guo Q; Bao C
    Ann Rheum Dis; 2014 Aug; 73(8):1591-3. PubMed ID: 24739327
    [No Abstract]   [Full Text] [Related]  

  • 18. Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease.
    Imura Y; Yukawa N; Handa T; Nakashima R; Murakami K; Yoshifuji H; Ohmura K; Ishii H; Nakata K; Mimori T
    Mod Rheumatol; 2018 Jul; 28(4):724-729. PubMed ID: 26872621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
    Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
    Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.
    Horai Y; Isomoto E; Koga T; Okada A; Kawashiri SY; Tamai M; Yamasaki S; Nakamura H; Origuchi T; Hamaguchi Y; Fujimoto M; Kuwana M; Kawakami A
    Mod Rheumatol; 2013 Jan; 23(1):190-4. PubMed ID: 22460910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.